Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.62+0.01 (+0.62%)
Close on Nov 13, 2026Market cap $60.63MP/E –Yield –
Tenax Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Tenax Therapeutics's enterprise value was -$64.00M on Nov 11, 2026, against -$43.66M a year earlier. Over the last 5 years it ranged from -$88.58M to $41.93B, with a median of -$565.55K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$64.00M | – |
| 2025 | Dec 31, 2025 | -$27.36M | – |
| 2024 | Dec 31, 2024 | -$77.21M | -115.0% |
| 2023 | Dec 29, 2023 | $513.07M | -90.4% |
| 2022 | Dec 30, 2022 | $5.34B | -87.3% |
| 2021 | Dec 31, 2021 | $41.93B | +11.7% |
| 2020 | Dec 31, 2020 | $37.55B | +147.0% |
| 2019 | Dec 31, 2019 | $15.20B | +436.7% |
| 2018 | Dec 31, 2018 | $2.83B | -87.2% |
| 2017 | Dec 29, 2017 | $22.13B | -74.8% |
| 2016 | Dec 30, 2016 | $87.72B | -40.6% |
| 2015 | Dec 31, 2015 | $147.55B | -14.6% |
| 2014 | Dec 31, 2014 | $172.74B | +252.1% |
| 2013 | Dec 31, 2013 | $49.06B | +44.7% |
| 2012 | Dec 31, 2012 | $33.90B | -37.9% |
| 2011 | Dec 30, 2011 | $54.59B | – |
See a number that looks wrong?